FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039108 [Registered on: 04/01/2022] Trial Registered Prospectively
Last Modified On: 30/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Single Arm Study 
Public Title of Study   Rising the temperature and reducing the flow rate of fluid meant for exchange of waste products from blood in hemo ( blood ) dialysis and its impact on removal of waste products in end stage kidney disease patients - a strategy for conservation of water 
Scientific Title of Study   Increasing dialysate temperature and reducing dialysate flow rate - Impact on solute clearance and a strategy for water conservation 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  sakthirajan ramanathan 
Designation  Assistant Professor 
Affiliation  madras medical college 
Address  Block-2 , 3H, Ramaniyam kamadhenu appts, ponnambalam salai, K.K.Nagar
Madras Medical College E.V.R.Periyar salai, chennai 600003
Chennai
TAMIL NADU
600078
India 
Phone  09444126080  
Fax    
Email  draatral@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  sakthirajan ramanathan 
Designation  Assistant Professor 
Affiliation  madras medical college 
Address  Block-2 , 3H, Ramaniyam kamadhenu appts, ponnambalam salai, K.K.Nagar
Madras Medical College, E.V.R.Periyar salai, chennai 600003
Chennai
TAMIL NADU
600078
India 
Phone  09444126080  
Fax    
Email  draatral@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dolphin solomon J 
Designation  senior resident 
Affiliation  madras medical college 
Address  Madras Medical College, E.V.R.Periyar salai, chennai 600003
Madras Medical College, E.V.R.Periyar salai, chennai 600003
Chennai
TAMIL NADU
600003
India 
Phone  09444126080  
Fax    
Email  mmcnephro@gmail.com  
 
Source of Monetary or Material Support  
Madras Medical College 
 
Primary Sponsor  
Name  Director Institute of Nephrology Madras Medical College 
Address  Institute of Nephrology, Madras Medical College, chennai 600003 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sakthirajan R  Madras Medical College  Institute of Nephrology, New Renal Block First floor, Room no : 102,E.V.R.PERIYAR salai, Chennai - 600003
Chennai
TAMIL NADU 
09444126080

draatral@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
madras medical college  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N186||End stage renal disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Increasing the Dialysate temperature to 38.5 degree centigrade and reducing the dialysate flow to 300 ml per minute  Increasing the Dialysate temperature from 37 degree to 38.5 degree centigrade and reducing the dialysate flow from 500 ml per minute to 300 ml per minute in every session of hemodialysis 
Comparator Agent  keeping the dialysate temperature at 37 degree centigrade and dialysate flow rate at 500 ml per minute  keeping the dialysate temperature at 37 degree centigrade and dialysate flow rate at 500 ml per minute in very session of Hemodialysis 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients with well functioning AVFistula. 2.Dialysis vintage more than 3 months.
3.No previous episodes of recurrent intradialytic hypotension.
4.left ventricle Ejection fraction > 40%.
 
 
ExclusionCriteria 
Details  1.Patients with tunneled or non tunneled catheters as the dialysis access.
2.Patients with recurrent intradialytic hypotension.
3.Patients with autonomic neuropathy.
4.Patients with left ventricle Ejection fraction˂40%.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Urea reduction ratio in every session of hemodialysis.
2. calculation of online Kt/V and time to reach the target of 1.2 in every session of dialysis. 
one month each for intervention and comparator arm that includes 8 to 12 session of hemodialysis  
 
Secondary Outcome  
Outcome  TimePoints 
1. number of episodes of intradialytic hypotension  one month each for intervention and comparator arm that includes 8 to 12 session of hemodialysis 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/01/2022 
Date of Study Completion (India) 31/05/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [draatral@gmail.com].

  6. For how long will this data be available start date provided 24-10-2022 and end date provided 24-10-2024?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary   This study aims to find out the impact on solute clearance and ability to achieve adequate dialysis by increasing the dialysate temperature from 37 to 38.5 degree centigrade and reducing dialysate flow from 500 ml to 300 ml per minute - as a strategy for conservation of water in hemodialysis.  End stage kidney disease patients who are on hemodialysis for more than three months and of age between 18 and 65 years with good functioning arterio venous fistula , with no evidence of recurrent intradialytic hypotension and left ventricular ejection fraction more than 40 % will be included. Those who are on tunneled or non tunneled catheter as access , who had recurrent intradialytic hypotension, those with autonomic neuropathy and left ventricle ejection fraction less than 40 % will be excluded. This is a non randomised single arm open labelled cross over trial. A sample of 30 patients will be given dialysis with a dialysate temperature of 37 degree and flow of 500 ml per minute for first month followed by same set of patients subjected to the intervention of increasing the dialysate temperature to 38.5 degree and reducing the flow to 300 ml per minute. Primary outcome will be calculation of urea reduction ratio and time to achieve online Kt/V of 1.2 at the end of each dialysis session for total of 8 to 12 session during the control period  and intervention period. secondary outcome is recording the number of episodes of intradialytic hypotension during both the period. 
Close